Mycophenolate mofetil in lupus nephritis refractary to intravenous cyclophosphamide

Statistics

Micofenolato de mofetilo en nefritis lúpica refractaria a ciclofosfamida intravenosa

Leonel Dazaa, Salvador Pérezb, Ulises Velascob, Martha Hernándeza

a Unidad de Investigación Clínica, Unidad Médica de Alta Especialidad IMSS, León Guanajuato, México,

b Departamento de Reumatología, Unidad Médica de Alta Especialidad IMSS, León Guanajuato, México,

Read

7100

Times
was read the article

3258

Total PDF

3842

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 12	41	34	75
2025 11	94	86	180
2025 10	5	75	80
2025 9	0	86	86
2025 8	0	78	78
2025 7	0	53	53
2025 6	2	50	52
2025 5	71	78	149
2025 4	65	50	115
2025 3	61	37	98
2025 2	51	43	94
2025 1	35	60	95
2024 12	33	43	76
2024 11	42	65	107
2024 10	35	31	66
2024 9	33	32	65
2024 8	39	43	82
2024 7	33	45	78
2024 6	50	25	75
2024 5	47	33	80
2024 4	36	25	61
2024 3	50	42	92
2024 2	45	36	81
2024 1	47	20	67
2023 12	33	28	61
2023 11	34	29	63
2023 10	36	35	71
2023 9	36	39	75
2023 8	27	18	45
2023 7	31	28	59
2023 6	36	34	70
2023 5	38	27	65
2023 4	14	11	25
2023 3	23	35	58
2023 2	25	38	63
2023 1	18	16	34
2022 12	58	37	95
2022 11	40	38	78
2022 10	26	37	63
2022 9	31	30	61
2022 8	56	49	105
2022 7	60	51	111
2022 6	72	41	113
2022 5	45	45	90
2022 4	28	46	74
2022 3	40	51	91
2022 2	26	39	65
2022 1	26	36	62
2021 12	26	63	89
2021 11	28	52	80
2021 10	30	38	68
2021 9	15	52	67
2021 8	16	35	51
2021 7	23	34	57
2021 6	27	43	70
2021 5	41	39	80
2021 4	57	95	152
2021 3	45	23	68
2021 2	43	21	64
2021 1	26	16	42
2020 12	18	23	41
2020 11	20	16	36
2020 10	22	16	38
2020 9	20	7	27
2020 8	19	22	41
2020 7	24	15	39
2020 6	33	14	47
2020 5	27	17	44
2020 4	28	20	48
2020 3	16	3	19
2020 2	2	0	2
2020 1	4	0	4
2019 9	6	0	6
2019 6	2	0	2
2019 3	2	0	2
2019 1	1	0	1
2018 5	4	1	5
2018 4	37	15	52
2018 3	33	13	46
2018 2	24	6	30
2018 1	10	6	16
2017 12	16	4	20
2017 11	17	7	24
2017 10	9	4	13
2017 9	11	3	14
2017 8	15	11	26
2017 7	19	11	30
2017 6	26	16	42
2017 5	33	11	44
2017 4	18	5	23
2017 3	16	9	25
2017 2	7	7	14
2017 1	18	6	24
2016 12	43	16	59
2016 11	28	9	37
2016 10	44	12	56
2016 9	33	7	40
2016 8	29	8	37
2016 7	18	15	33
2016 4	2	0	2
2016 1	1	0	1
2015 12	3	0	3
2015 10	2	0	2
2015 9	3	0	3
2015 8	1	0	1
2015 7	8	13	21
2015 6	23	12	35
2015 5	21	7	28
2015 4	21	18	39
2015 3	14	4	18
2015 2	15	9	24
2015 1	15	10	25
2014 12	18	10	28
2014 11	17	20	37
2014 10	11	11	22
2014 9	15	11	26
2014 8	16	16	32
2014 7	18	7	25
2014 6	32	18	50
2014 5	32	14	46
2014 4	24	12	36
2014 3	39	19	58
2014 2	34	10	44
2014 1	19	29	48
2013 12	19	15	34
2013 11	15	12	27
2013 10	36	8	44
2013 9	22	18	40
2013 8	25	13	38
2013 7	23	9	32
2013 6	23	7	30
2013 5	22	8	30
2013 4	22	7	29
2013 3	13	6	19
2013 2	16	9	25
2013 1	14	6	20
2012 12	22	6	28
2012 11	11	5	16
2012 10	9	2	11
2012 9	12	3	15
2012 6	4	0	4
2012 4	3	0	3
2012 3	5	0	5
2012 2	7	0	7
2012 1	3	0	3
2011 12	8	0	8
2011 11	5	0	5
2011 10	3	0	3
2011 9	2	0	2
2011 8	3	0	3
2011 7	1	0	1
2011 5	5	0	5
2011 4	1	0	1
2011 3	2	0	2
2011 2	5	0	5
2011 1	6	0	6
2010 12	3	0	3
2010 11	5	0	5
2010 10	3	0	3
2010 9	1	0	1
2010 8	10	0	10
2010 7	7	0	7
2010 6	3	0	3
2010 5	14	0	14
2010 4	4	0	4
2010 3	7	0	7
2010 2	26	0	26
2010 1	2	0	2
2009 12	4	0	4
2009 11	6	0	6
2009 10	9	0	9
2009 9	7	0	7
2009 8	7	0	7
2009 7	6	0	6
2009 6	6	0	6
2009 5	18	0	18
2009 4	13	0	13
2009 3	7	0	7

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter